Form 8-K - Current report:
SEC Accession No. 0001104659-12-012515
Filing Date
2012-02-24
Accepted
2012-02-24 16:11:45
Documents
5
Period of Report
2012-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-5616_48k.htm 8-K 28681
2 EX-1.1 a12-5616_4ex1d1.htm EX-1.1 237460
3 EX-5.1 a12-5616_4ex5d1.htm EX-5.1 11141
4 EX-99.1 a12-5616_4ex99d1.htm EX-99.1 16745
5 GRAPHIC g56164mmi001.jpg GRAPHIC 3870
  Complete submission text file 0001104659-12-012515.txt   300797
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 12638309
SIC: 2835 In Vitro & In Vivo Diagnostic Substances